Business
Cytophage Reports AGM Results and Announces Upcoming Investor Call
(TheNewswire) Winnipeg – TheNewswire - June 27, 2024 - Cytophage Technologie...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":"Cytophage Reports AGM Results and Announces Upcoming Investor Call\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Winnipeg –\n \n \n TheNewswire\n-\n \n \n June 27, 2024 - Cytophage Technologies Ltd.\n(\n \n \n TSXV:CYTO\n \n \n ) (“\n \n \n Cytophage\n \n \n ” or the “\n \n \n Company\n \n \n ”),\n \n \n \n the only publicly traded phage company\nthat is focused on bacteriophage solutions for both animal health and\nhuman health, is pleased to report the results of its annual general\nmeeting (the \"\n \n \n \n \n AGM\n \n \n \n \n \") of shareholders held on June 25,\n2024 in Toronto, ON.\n \n \n \n \n \n \n At\nthe AGM, shareholders elected the slate of directors proposed in the\nManagement Information Circular dated May 24, 2024 (the\n“\n \n \n \n \n Circular\n \n \n \n \n ”) which was sent to shareholders in\nconnection with the AGM, including new member Michael Sorkin, a 30+\nyear\n \n \n \n commercial sales and\nmarketing\n \n \n \n veteran of medical devices and services\naround the world, further expanding the Company’s expertise in\ngetting products to market.\n \n \n \n \n \n \n Chairman of the Board Harold Wolkin commented: “Since going public\nin early February, we have managed to build a high-calibre board that\nI am proud to chair. On behalf of all directors, I welcome Michael to\nour ranks, and I look forward to incorporating the commercialization\nexpertise he brings to the table. Andy Hurley decided not to stand for\nre-election to the board, and I would like to thank him for his\ninsights and contributions to the organization.”\n \n \n \n \n \n Michael Sorkin brings invaluable global commercial\nexperience in medical devices and services, having launched and\ndeveloped diverse and inclusive organizations for KMT Medical,\nHollister, and Boston Scientific. Since 1995, Michael has led and has\nhad full P&L responsibility for country and regional commercial\noperations while living in Europe, Australia/NZ, Japan, Asia, and the\nUS. Most recently, as Managing Director of KMT Medical, Chair of the\nKMT Management Board, and member of the Executive Committee, Michael\nhad full P&L responsibility for a\n \n \n 10-country, multi-national homecare business.\n \n \...